- CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell…
Number of the records: 1  

CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell vaccine confers significant antitumor effects

  1. CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell vaccine confers significant antitumor effects / X.B. Zhuang ... [et al.]. Neoplasma Vol. 62, no. 6 (2015), s. 905-913
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.